Cargando…

Atrial Fibrillation as a Risk Factor for Major Adverse Cardiac and Cerebrovascular Events after Non-cardiac Surgery

Detalles Bibliográficos
Autores principales:	Shin, Dong Geum, Lim, Hong Euy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974664/ https://www.ncbi.nlm.nih.gov/pubmed/31960634 http://dx.doi.org/10.4070/kcj.2019.0386

Ejemplares similares

Esophageal Endoscopy after High-power and Short-duration Ablation in Atrial Fibrillation Patients
por: Shin, Dong Geum, et al.
Publicado: (2020)

Major Adverse Cardiac and Cerebrovascular Events in Patients Undergoing Simultaneous Heart Surgery and Carotid Endarterectomy
por: Gerfer, Stephen, et al.
Publicado: (2023)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

Atrial high-rate episodes predict major adverse cardio/cerebrovascular events in patients with cardiac implantable electrical devices
por: Chen, Ju-Yi, et al.
Publicado: (2021)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy
por: Tani, Tomoko, et al.
Publicado: (2011)

Circulating Magnesium and Risk of Major Adverse Cardiac Events among Patients with Atrial Fibrillation in the ARIC Cohort
por: Li, Linzi, et al.
Publicado: (2023)

Mitral annular calcification is associated with atrial fibrillation and major cardiac adverse events in atrial fibrillation patients: A systematic review and meta-analysis
por: Li, Yimin, et al.
Publicado: (2019)

Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome
por: Baluja, Aurora, et al.
Publicado: (2019)

Major Adverse Cardiac and Cerebrovascular Events in Geriatric Patients with Obstructive Sleep Apnea: An Inpatient Sample Analysis
por: Desai, Rupak, et al.
Publicado: (2023)

Appropriateness of concomitant surgical ablation for atrial fibrillation during redo cardiac surgery
por: Sef, Davorin, et al.
Publicado: (2023)

Changes in geriatric nutritional risk index and risk of major adverse cardiac and cerebrovascular events in incident peritoneal dialysis patients
por: Lee, Mi Jung, et al.
Publicado: (2017)

Safety and efficacy of intracardiac echocardiography–guided zero-fluoroscopic cryoballoon ablation for atrial fibrillation: a prospective randomized controlled trial
por: Ahn, Jinhee, et al.
Publicado: (2023)

Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
por: Sato, Jun, et al.
Publicado: (2023)

Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands
por: van Doorn, Sander, et al.
Publicado: (2018)

Recurrence of atrial fibrillation following non-cardiac surgery or acute illness: A common but rarely detected complication
por: Barrios Espinosa, Cristian, et al.
Publicado: (2020)

Atrial fibrillation after cardiac surgery
por: İşcan, Şahin, et al.
Publicado: (2015)

Commentary: Surgical treatment of atrial fibrillation at the time of cardiac surgery: Just do it
por: Hodges, Kevin, et al.
Publicado: (2021)

Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery
por: Larmann, Jan, et al.
Publicado: (2020)

Prevalence and trends of perioperative major adverse cardiovascular and cerebrovascular events during cancer surgeries
por: Ramamoorthy, Venkataraghavan, et al.
Publicado: (2023)

Cerebrovascular Dysfunction in Atrial Fibrillation
por: Junejo, Rehan T., et al.
Publicado: (2020)

Prediction model for postoperative atrial fibrillation in non-cardiac surgery using machine learning
por: Oh, Ah Ran, et al.
Publicado: (2023)

Atrial fibrillation post cardiac bypass surgery
por: Mostafa, Ashraf, et al.
Publicado: (2012)

Impact of Clopidogrel Stop Interval on Major Adverse Bleeding Events in Cardiac Surgery
por: Huo, Bright, et al.
Publicado: (2021)

Microvascular reactivity as a predictor of major adverse events in patients with on-pump cardiac surgery
por: Cho, Ah-Reum, et al.
Publicado: (2022)

Impact of statin intensity on adverse cardiac and cerebrovascular events in older adult patients with myocardial infarction
por: Moon, In Tae, et al.
Publicado: (2021)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Associations of Warfarin Use with Risks of Ischemic Cerebrovascular Events and Major Bleeding in Patients with Hyperthyroidism-Related Atrial Fibrillation
por: Liu, Sian-De, et al.
Publicado: (2022)

Postoperative Adverse Cardiovascular Events Associated with Leptin and Adverse Age After Elective Major Non-Cardiac Surgery: An Asian Single-Center Study
por: Gu, Zheng, et al.
Publicado: (2018)

Anemia as an Independent Predictor of Adverse Cardiac Outcomes in Patients with Atrial Fibrillation
por: Lee, Wen-Hsien, et al.
Publicado: (2015)

Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes
por: Csengeri, Dora, et al.
Publicado: (2021)

Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction
por: Wang, Qian, et al.
Publicado: (2017)

Carotid total plaque area as an independent predictor of short-term subclinical polyvascular atherosclerosis progression and major adverse cardiac and cerebrovascular events
por: Genkel, Vadim, et al.
Publicado: (2023)

Preoperative left atrial volume index may be associated with postoperative atrial fibrillation in non-cardiac surgery
por: Oh, Ah Ran, et al.
Publicado: (2022)

High-Density Lipoprotein Cholesterol Efflux Capacity as a Surrogate Marker for Major Cardiac Adverse Events in Japanese Patients
por: Komatsu, Tomohiro, et al.
Publicado: (2021)

Landiolol for managing atrial fibrillation in post-cardiac surgery
por: Fellahi, Jean-Luc, et al.
Publicado: (2018)

Atrial fibrillation after cardiac surgery: to screen or not to screen?
por: Casadei, Barbara, et al.
Publicado: (2021)

Long-Term Outcomes of Preoperative Atrial Fibrillation in Cardiac Surgery
por: Kim, Hyo-Hyun, et al.
Publicado: (2022)

Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
por: Imperiali, Claudia E., et al.
Publicado: (2020)

Atrial fibrillation in patients with cardiac amyloidosis and heart failure: a desperate cause?
por: Sellal, Jean-Marc, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j47282d2gh1cu5jgml3mrrb4ud